CYP2W1 Polyclonal Antibody

CYP2W1 encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids.

The CYP2W1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of CYP2W1 protein expression. This antibody is produced through a rigorous process, ensuring its high affinity and specificity towards the target protein.

CYP2W1, a member of the cytochrome P450 superfamily, plays a crucial role in the metabolism of various endogenous and exogenous compounds. It is predominantly expressed in the gastrointestinal tract, making it an important biomarker for gastrointestinal cancers.

The CYP2W1 Polyclonal Antibody has been extensively validated for its performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other cytochrome P450 isoforms, ensuring accurate and reliable results.

With its exceptional sensitivity, this antibody allows for the detection of low levels of CYP2W1 protein expression, enabling researchers to study its role in cancer development and progression. Its high specificity ensures minimal background noise, enhancing the accuracy of experimental data.

The CYP2W1 Polyclonal Antibody is supplied in a convenient and ready-to-use format, making it suitable for both research and diagnostic purposes. It is available in various sizes to accommodate different experimental needs.

In summary, the CYP2W1 Polyclonal Antibody is a valuable tool for researchers and clinicians interested in studying the expression and function of CYP2W1 protein. Its high specificity, sensitivity, and ease of use make it an essential component in cancer research and diagnostics.